Liege, Belgium, 2 June 2022 - 7:30 CET - Mithra Pharmaceuticals SA (Euronext Brussels: MITRA) (the "Company" or "Mithra"), a company dedicated to Women's Health, today announces that Goldman Sachs International ("GSI") has elected to exercise the last call option in relation to the outstanding drawdown of EUR 5 million, and provides additional information on its financing strategy.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Mithra Pharmaceuticals SA published this content on 02 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 June 2022 05:41:06 UTC.